当热门股票价格飞速上涨而自己错失良机时，着实令人不快。比如说，注射型糖尿病和减重药物GLP-1类药物最近大火，带动制药股诺和诺德（Novo ...

In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $45.71, indicating a +0.29% shift from the previous trading day.

Research by a Stanford University team of scientists has shed new light on how and why neural stem cells (NSCs), the cells ...

Cathie Wood is the founder and CEO of Ark Invest, an asset management firm focusing on disruptive innovation, with ...

CRISPR-Cas systems help to protect bacteria from viruses. Several different types of CRISPR-Cas defense systems are found in ...

Neural stem cells, which create new neurons in the brain, become less active with age due to elevated glucose levels.

Age impedes the ability of the brain’s stem cells to churn out new cells, but the study’s authors found that reducing the ...

CRISPR Gene editing therapy is used for the first time in living humans with amazing results.0:00 Introduction 0:53 What is CRISPR?2:05 How Does CRISPR work?3:18 The Experiment5:30 The Results9:31 ...

Market-beating returns could be on the way for patient investors in these two up-and-coming healthcare growth stocks.

We’re only a few months a way from the end of the year, but pharma companies still have a steady stream of clinical trial ...

In an audacious bid to rewrite the narrative of cancer treatment, scientists are converging on an ingenious approach: ...

Scientists have revealed how Fanzor2's divergence from bacterial ancestors may make it a useful tool for future genomic engineering endeavors.